The next era of healthcare is personal

mRNA technology functions as an information-based platform, enabling the rapid development of targeted medical solutions by treating biology as a flow of data. Stéphane Bancel, CEO of Moderna, highlights how this approach transforms healthcare from an analog, trial-and-error model into a precise, individualized system. By leveraging mRNA to provide specific instructions to the immune system, Moderna is advancing personalized cancer immunotherapies and rare disease treatments. The integration of AI and robotics further accelerates this evolution by optimizing drug discovery feedback loops and minimizing human error in manufacturing. These advancements promise to significantly reduce the time and cost of drug development while increasing the probability of clinical success, ultimately shifting the focus of medicine toward proactive prevention and customized patient care.